APA (7th ed.) Citation

D, H., MD, G., JM, J., E, G., A, I., F, L., . . . RM, L. (2017). The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. Molecular cancer, 16(1), 146. https://doi.org/10.1186/s12943-017-0713-9

Chicago Style (17th ed.) Citation

D, Hormaechea-Agulla, et al. "The Oncogenic Role of the In1-ghrelin Splicing Variant in Prostate Cancer Aggressiveness." Molecular Cancer 16, no. 1 (2017): 146. https://doi.org/10.1186/s12943-017-0713-9.

MLA (9th ed.) Citation

D, Hormaechea-Agulla, et al. "The Oncogenic Role of the In1-ghrelin Splicing Variant in Prostate Cancer Aggressiveness." Molecular Cancer, vol. 16, no. 1, 2017, p. 146, https://doi.org/10.1186/s12943-017-0713-9.